Vanguard Group Inc Pds Biotechnology Corp Put Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding PDSB
# of Institutions
60Shares Held
4.23MCall Options Held
170KPut Options Held
6.7K-
Black Rock Inc. New York, NY487KShares$613,5780.0% of portfolio
-
Geode Capital Management, LLC Boston, MA417KShares$525,6930.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA247KShares$311,1910.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il220KShares$277,4700.0% of portfolio
-
Blair William & CO Chicago, IL158KShares$198,4500.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $35.9M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...